Patent ID: 11925636
Assignee: ANTECIP BIOVENTURES II LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 10:
11. A method of treating major depressive disorder in an adult human patient who is consuming alcohol, comprising administering, twice a day, a dosage form to a human patient in need thereof, wherein the dosage form comprises 105 mg of bupropion hydrochloride, or a molar equivalent amount of another salt form of bupropion or the free base form of bupropion, mg of dextromethorphan hydrobromide, or a molar equivalent amount of another salt form of dextromethorphan or the free base form of dextromethorphan, and a polymer,
wherein if the human patient is a male, the human patient is consuming two servings or less of alcohol per day; and
if the human patient is a female, the human patient is consuming one serving or less of alcohol per day.